Takeda Pharmaceuticals announces Japan MAP failure
November 22, 2011
Sophie Ashley - TPW
Takeda Pharmaceuticals has announced that its mutual agreement procedure (MAP) with the National Tax Agency in Japan did not result in an agreement with the US.
The company applied for the MAP in July 2008 to eliminate $1.1 billion of double taxation between the two revenue authorities.
Sorry. You must be a subscriber to view this article. Alternatively, why not take a free trial? To subscribe and access this article immediately simply click here or call +44(0)207 779 8380.